BEVACIZUMAB USE IN METASTATIC COLORECTAL CANCER IN THE FACILITIES OF DAY HOSPITAL OF REGIONAL ОNCOLOGY DISPENSARY

Purpose. To conduct retrospective analysis of first line therapy with bevacizumab received by patients treated in Perm Regional Oncology Dispensary.Methods. Analysis of treatment results of 28 patients who received first line metastatic colorectal cancer (mCRC) treatment including bevacizumab in Per...

Full description

Bibliographic Details
Main Authors: T. A. Malysheva, O. A. Orlov
Format: Article
Language:Russian
Published: “ABV-press” Publishing house”, LLC 2015-02-01
Series:Тазовая хирургия и онкология
Subjects:
Online Access:https://ok.abvpress.ru/jour/article/view/78